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Background: Compound FK506 is an immunosuppressant agent that is frequently used to prevent
rejection of solid organs upon transplant. However, nephrotoxicity due to apoptosis and inﬂammatory
response mediated by FK506 limit its usefulness. In this study, the protective effect of Korean Red
Ginseng (KRG) against FK506-induced damage in LLC-PK1 pig kidney epithelial cells was investigated.
Methods: LLC-PK1 cells were exposed to FK506 with KRG and cell viability was measured. Western
blotting and RT-PCR analyses evaluated protein expression of MAPKs, caspase-3, and KIM-1. TLR-4 gene
expression was assessed. Caspase-3 activities were also determined. The number of apoptotic cells was
measured using an image-based cytometric assay.
Results: The reduction in LLC-PK1 cell viability by 60mM FK506 was recovered by KRG cotreatment in a
dose-dependent manner. The phosphorylation of p38, p44/42 MAPKs (ERK), KIM-1, cleaved caspase-3,
and TLR-4 mRNA expression was increased markedly in LLC-PK1 cells treated with 60mM FK506. How-
ever, with the exception of p-ERK, elevated levels of p-p38, KIM-1, cleaved caspase-3, and TLR-4 mRNA
expression were signiﬁcantly decreased after cotreatment with KRG. Activity level of caspase-3 was also
attenuated by KRG cotreatment. Moreover, image-based cytometric assay showed that apoptotic cell
death was increased by 60mM FK506 treatment, whereas it was decreased after cotreatment with KRG.
Conclusion: Taken together, these results suggest that the molecular mechanism of KRG in the FK506-
induced nephrotoxicity may lead to the development of an adjuvant for the inhibition of adverse ef-
fect FK506 in the kidney.
Copyright 2016, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
FK506 is a macrolide immunosuppressant agent isolated from
the fungus Streptomyces tsukubaensis. It is a selective anti-T-
lymphocyte agent and is used to prevent allograft rejection af-
ter human liver, kidney and heart transplantation, as well as
autoimmune diseases [1e4]. FK506 treatment induces nephro-
toxicity in 17e44% of renal transplant recipients and in 18e42% ofkyunkwan University, Suwon 440
e, Gachon University, Seongnam 13
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scribed in this study.
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d/4.0/).
, Protective effect of Korean Re
0.1016/j.jgr.2016.05.002liver transplant recipients [5]. This has limited the clinical use of
FK506.
The mechanisms of FK506-induced nephrotoxicity are not
completely resolved. The main mechanisms causing side effects are
changes in glomerular and tubular function by increases in
apoptosis and inﬂammatory response in proximal tubular cells
[3,6]. Minimizing FK506-induced nephrotoxicity is important for
improved long-term renal allograft survival. Production of nitric-746, Korea.
120, Korea.
.
eng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
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suppressed by green tea extract in mice and LLC-PK1 cells treated
with FK506 [7,8]. Polyphenols found in green tea signiﬁcantly
reduce FK506-induced cytotoxicity by suppressing the release of
cytochrome c, activating caspase-3 and suppressing increased
intracellular levels of reactive oxygen species (ROS) [7,9]. Consid-
ering the gravity of the problem, few studies have examined how
best to minimize FK506-induced nephrotoxicity.
Korean Red Ginseng (KRG), a steamed and dried root of Panax
ginsengMeyer, has been used formillennia in Korea and other Asian
countries as a traditional oriental medicine to treat illness and
promote health [10,11]. Biological and pharmacological activities
can be enhanced through heat and steam processes [12]. The va-
riety of pharmacological activities attributed to KRG include anti-
apoptotic [13,14], antiinﬂammatory [15,16] and antioxidant effects
[12,17,18].0
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Fig. 1. Effect of KRG and its fractions on the FK506-induced nephrotoxicity in LLC-PK1 cell
Comparison in protective effect of KRG and fractions against FK506-induced nephrotoxicity
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nephrotoxicity have been studied. KRG can prevent nephro-
toxicity induced by gentamicin by decreasing oxidative stress
and apoptosis of rat renal tubular cells [19,20]. In HK-2 prox-
imal tubular cells, KRG-mediated reduction of nephrotoxicity
induced by chronic cyclosporine, proinﬂammatory and proﬁ-
brotic molecules including induced nitric oxide synthase and
cytokines, and of apoptotic cell death [21]. KRG treatment also
reportedly reduces autophagosome formation and autophagic
aggregates by decreasing the expression of caspase-3 and LC3-
II in mice [22]. In another study, KRG prevented nephrotoxicity
induced by gentamicin through the decrease of the levels of
indicators of renal dysfunction, inﬂammatory cytokine expres-
sion, apoptosis, and malondialdehyde content in rats [23].
The collective data prompted the present study to explore the
potential of KRG as a useful agent to prevent or protect FK506-10 25 50 100
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inﬂammatory, and antioxidant effects.2. Materials and methods
2.1. Chemicals
FK506 was purchased from Sigma Aldrich (St. Louis, MO, USA).
Ez-Cytox cell viability assay kit was purchased fromDail Lab Service
Co. (Seoul, Korea). Caspase-3 colorimetric assay kit was purchased
from BioVison (Milpitas, CA, USA). Tali Apoptosis Kit was purchased
from Invitrogen (Carlsbad, CA, USA). Dulbecco’s modiﬁed Eagle’s
medium (DMEM) and fetal bovine serum (FBS) was purchased from
Cellgro (Manassas, VA, USA) and Invitrogen Co. (Grand Island, NY,
USA). KRG was provided by Korea Ginseng Corporation (Daejeon,
Republic of Korea).Cont. FK506 10 50
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Fig. 2. Effect of KRG on MAPKs, KIM-1 and caspase-3 activation in the FK506-induced nephr
KIM-1, cleaved caspase-3 and GAPDH. *p< 0.05 compared to the FK506-treated value.
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KRG extracts were manufactured from the roots of 6-year-old
fresh Panax ginseng provided by Korea Ginseng Corporation. KRG
extract (10 g) was solvent-partitioned in sequence with hexane,
dichloromethane, ethyl acetate, and n-butanol, which yielded
103 mg, 325 mg, 134 mg, and 246 mg of dried organic fraction,
respectively (Fig. 1A).2.3. Cell culture and cell viability assay
LLC-PK1 pig kidney epithelial cells (CL-101) were used to eval-
uate renoprotective activity against FK506-induced cytotoxicity as
reported previously [9]. LLC-PK1 cells were purchased from the
American Type Culture Collection (Rockville, MD, USA), and
cultured in DMEM supplemented with 10% FBS and 1% penicillin/0.0
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J Ginseng Res 2016;-:1e64streptomycin (Invitrogen), and 4mM L-glutamine in an atmosphere
of 5% CO2 at 37C. Viability of cells was determined by the Ez-Cytox
cell viability assay, which is based on the reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to
insoluble formazan. Cells grown to approximately 80% conﬂuence
were seeded in wells of 96-well culture plates at 1104 cells per
well and incubated for 24 h for adhesion. Then cells were treated
with various concentrations (30mM, 40mM, 50mM, 60mM, 90mM and
100mM) of FK506 for 24 h to conﬁrm its appropriate concentration
to induce apoptosis. After incubation, 10 mL of Ez-Cytox reagent was
added to each well and incubated for 2 h. Cell viability was
measured by absorbance at 450 nm using a PowerWave XS
microplate reader (Bio-Tek Instruments, Winooski, VT, USA).
To verify the protective effects of KRG and its fractions, LLC-PK1
cells seeded in wells of 96-well culture plates at 1104 cells per
well were exposed to FK506 with control (0.5% dimethylsulfoxide)
or indicated concentrations of KRG and its fractions for 24 h. Then
cell viability was measured by Ez-Cytox reagent as described above.0.0
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2.4. Western blotting analysis
LLC-PK1 cells cultured in wells of six-well plates were treated
with 10 mg/mL KRG or 50 mg/mL KRG (for 24 h) and lysed with RIPA
buffer [20mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM Na2EDTA, 1mM
EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5mM sodium pyro-
phosphate, 1mM beta-glycerophosphate, 1mM Na3VO4, 1 mg/mL
leupeptin; Cell Signaling Technology, Beverly, MA, USA] supple-
mented with 1mM phenylmethylsulfonyl ﬂuoride (PMSF) imme-
diately before use. Protein concentration was determined using the
Pierce BCA Protein Assay Kit (Thermo Fisher Scientiﬁc, Pittsburgh,
PA, USA). Equal amounts (20 mg/lane) of protein (whole-cell ex-
tracts) were separated by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred to PVDF trans-
fer membranes. Speciﬁc proteins were analyzed with epitope-
speciﬁc primary antibody to MAPK species [p38, phospho-p38,
p44/42 extracellular signal-regulated kinase (ERK), and phospho-
p44/42 (pERK)], cleaved caspase-3, kidney injury molecule-1
(KIM-1), and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), and horseradish peroxidase (HRP) conjugated antirabbit
antibodies (Cell Signaling Technology). Bound antibodies were
detected using ECL Advance Western Blotting Detection Reagents
(GE Healthcare, Buckinghamshire, UK) and visualized using a
FUSION Solo Chemiluminescence System (PEQLAB Biotechnologie
GmbH, Erlangen, Germany).0.0
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Fig. 3. Effect of KRG on caspase-3 activity and TLR-4 mRNA expression on the FK506-
induced nephrotoxicity in LLC-PK1 cells. (A) Activity level of caspase-3; (B) mRNA level
of TLR-4. *p< 0.05 compared to the FK506-treated value.2.5. RT-PCR
LLC-PK1 cells cultured in wells of six-well plates were treated
with 10 mg/mL KRG or 50 mg/mL KRG for 24 h. The cells were
collected and total mRNA was isolated using a RNeasy Mini Kit
(Qiagen, Valencia, CA, USA) according to the protocol of the
manufacturer. The concentration and integrity of mRNA was eval-
uated using a spectrophotometer (Nanodrop Technologies, Wil-
mington, DE, USA). Total RNA (1 mg) was pretreatedwith RNase-free
DNase I for 20 min at 37C to remove genomic DNA prior to use in
cDNA synthesis using a RevertAid First Strand cDNA Synthesis Kit
(Thermo Fischer Scientiﬁc). PCR ampliﬁcation of Toll-like receptor
(TLR)-4 was performed with 2 mL cDNA using Ex Taq Polymerase
(TaKaRa Bio, Shiga, Japan). The PCR products were electrophoresed
in a 2% polyacrylamide gel and visualized on a gel nucleic acid
bioimaging device (NaBI; NEOScience, Gyeonggi-do, Korea) by
ethidium bromide staining. GAPDHwas used as an internal control.
The primer sets were as follows: TLR-4, forward 50-CAG ATA AGC
GAG GCC GTC ATT-30 and reverse 50-TTG CAG CCC ACA AAA AGC A-Please cite this article in press as: Lee D, et al., Protective effect of Korean Re
Ginseng Research (2016), http://dx.doi.org/10.1016/j.jgr.2016.05.00230: GAPDH, forward 50-ACA TCA TCC CTG CTT CTA CTG G-30 and
reverse 50- CTC GGA CGC CRG CTT CAC-30.2.6. Caspase activity assay
Caspase-3 activity was determined by using colorimetric assay
kits according to the protocol of the manufacturer (BioVison, Mil-
pitas, CA, USA). LLC-PK1 cells (1106) seeded in 100-mm dishes
were treated with 10 mg/mL KRG or 50 mg/mL KRG. After incubationd Ginseng against FK506-induced damage in LLC-PK1 cells, Journal of
D. Lee et al / Renoprotection effect of ginseng 5for 2 h, 60mM FK506 was added to each well and incubated for 24 h.
Cells were lysed in 50 mL of lysis buffer and incubated on ice for
10 min. Then, 50 mL of 2 reaction buffer containing 10mM
dithiothreitol and 5 mL of 4mM DEVD-pNA substrate was added to
each of the lysed samples and incubated for an additional 1 h at
37C. Caspase activity was measured by absorbance at 400 nm
using a PowerWave XS microplate reader (Bio-Tek Instruments).
2.7. Image-based cytometric assay
LLC-PK1 cells seeded in wells of six-well plates were treated
with 10 mg/mL KRG or 50 mg/mL KRG. After incubation for 2 h, 60mM
FK506 was added to each well and incubated for 3 h. Cells were
stained with Annexin V Alexa Fluor 488 (Thermo Fischer Scientiﬁc,
Waltham, MA, USA.) in darkness for 20 min after suspension in
Annexin binding buffer and stained with propidium iodide in
darkness for 5 min after suspension in Annexin binding buffer. The
number of dead and apoptotic cells was measured using a Tali
image-based cytometer (Invitrogen). This assay identiﬁed apoptotic
cells stained green by Annexin V Alexa Fluor 488 from dead cells
stained red from propidium iodide and green, and non-staining live
cells.
2.8. Statistical analyses
Statistical signiﬁcance was determined through analysis of
variance (ANOVA) followed by a multiple comparison test with a
Bonferroni adjustment. Values of p< 0.05 were considered statis-
tically signiﬁcant. Analyses were performed using SPSS ver. 19.0
software (SPSS Inc., Chicago, IL, USA).
3. Results and discussion
FK506 is beneﬁcial in avoiding solid organ transplant rejection.
However, this use is hindered by the associated nephrotoxicity. The
mechanisms of FK506-induced nephrotoxicity are poorlyA
Control FK506 (60 μM)
FK506 (60 μM)
+ KRG (10 μg/ml)
FK506 (60 μM)
+ KRG (50 μg/ml)
Fig. 4. Effects of KRG on apoptosis on the FK506-induced nephrotoxicity in LLC-PK1 cells.
Annexin V and shown in green cells. *p< 0.05 compared to the FK506-treated value.
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Ginseng Research (2016), http://dx.doi.org/10.1016/j.jgr.2016.05.002understood. Previous studies suggest that FK506 can produce ROS
and can perturb antioxidant defense in the proximal tubules, which
depend on oxidative phosphorylation for energy production, and
which thus may be susceptible to oxidative stress [24,25]. The
result can be apoptosis and inﬂammation in proximal tubular cells.
In the present study, LLC-PK1 renal tubular epithelial cells were
used to determine the protective effect of KRG against FK506-
induced nephrotoxicity. Cytotoxicity of FK506 was explored using
various concentrations of FK506. LLC-PK1 cell viability was reduced
by 61.2% as compared with the control group (0.5% DMSO) after
60mM FK506 treatment (Fig. 1B), and 60mM FK506 was selected to
evaluate the protective effect against FK506-induced nephrotoxi-
city in the following experiments. The reduction in cell viability by
60mM FK506 was ameliorated by KRG cotreatment in a dose-
dependent manner. Particularly, the reduced LLC-PK1 cell
viability was ameliorated by up to 81.8% after cotreatment with
50 mg/mL KRG (Fig. 1C). In a comparative experiment with KRG
fractions, the butanol fraction mainly consisting of ginsenosides
showed the strongest activity. LLC-PK1 cell viability was improved
by up to 82.0% by pretreatment with 0.5 mg/mL of butanol fraction
(Fig. 1CeG). Therefore, ginsenosides may be the main active in-
gredients of KRG to protect FK506-induced nephrotoxicity.
FK506 promotes death, proinﬂammatory response, and proﬁ-
brotic responses as well as nephrotoxic responses in tubular cells by
activation of protein kinases, such as the TAK1/JNK/AP-1 and TLR4/
Myd88/IRAK pathways [26]. KIM-1 is a type I transmembranous
protein that can be exploited as a sensitive biomarker of FK506-
induced nephrotoxicity in rat proximal tubule epithelial cells [4].
FK506 also causes a signiﬁcant increase in apoptosis of LLC-PK1
cells through a release of cytochrome c and activation of caspase-
3 [7,9].
Considering the aforementioned protective effects of KRG on
cell viability, we further evaluated the effect of KRG on MAPKs,
caspase-3 activation, and TLR-4 mRNA expression on the FK506-
induced nephrotoxicity in LLC-PK1 cells. The phosphorylation of
p38 MAPK and p44/42 MAPK (ERK), and the production of KIM-1B
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(A) Visualization of apoptosis detection. (B) Percentage of apoptotic cells stained with
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J Ginseng Res 2016;-:1e66and cleaved caspase-3 were increased markedly in LLC-PK1 cells
treated with 60mM FK506. However, with the exception of p-ERK,
elevated levels of p-p38, KIM-1, cleaved caspase-3, and TLR-4
mRNA expression were signiﬁcantly decreased after cotreatment
with KRG (Fig. 2AeC). Caspase-3 activity supported the Western
blot result; activity was increased signiﬁcantly after treatment with
60mM FK506, whereas either concentration of KRG completely
abrogated FK506-induced caspase-3 activity to near basal levels
(Fig. 3A). Similarly, increased TLR-4 mRNA expression also
decreased by treatment with either concentration of KRG (Fig. 3B).
In the study about the protective effects of green tea extract and
tea polyphenols against FK506-induced cytotoxicity, treatment of
the cells with 50mM FK506 induced a signiﬁcant increase in
apoptotic cell death as demonstrated by Annexin V binding from
2.6% to 14.5% in LLC-PK1 cells [7]. To explore whether KRG could
decrease FK506-induced apoptosis in LLC-PK1 cells through
Annexin V Alexa Fluor 488 and propidium iodide staining, LLC-PK1
cells were treated with we treated with 10 mg/mL KRG or 50 mg/mL
KRG. Apoptotic cell death evident by Annexin V staining was
increased from 1.3% to 13.3% by treatment with 60mM FK506
treatment, whereas apoptosis decreased 6.6% after cotreatment
with either concentration of KRG (Fig. 4A). The percentage of
apoptotic cells is depicted in the bar graph of Fig. 4B.
In an earlier study of the beneﬁcial effects of KRG on drug-
induced renal toxicity, KRG treatment signiﬁcantly reduced the
expression of both active caspase-3 and LC3-II in cyclosporine-
induced autophagic cell death in mice [22]. Also, KRG treatment
signiﬁcantly reduced apoptotic cell death, as demonstrated by
Annexin V binding by reducing oxidative stress in mice and prox-
imal tubular cells (HK-2) [21]. In gentamicin-induced nephrotoxi-
city, KRG treatment signiﬁcantly attenuated oxidative stress-
mediated apoptosis by reducing the expression of mitochondrial
Bax, cytosolic cytochrome c, and cleaved caspase-9 and caspase-3,
along with a decrease in bcl-2 expression in rat NRK-52E renal
tubular epithelial cells [20]. In cisplatin-induced nephrotoxicity,
KRG treatment signiﬁcantly decreased the levels of indicators of
renal dysfunction, inﬂammatory cytokine expression, apoptosis,
and malondialdehyde content in rats [23].
In summary, the protective effect andmechanism of KRG against
FK506-induced nephrotoxicity was demonstrated in LLC-PK1 cells.
KRG has an antiapoptotic effect by inhibition of p38 phosphoryla-
tion and activation of caspase, and an antiinﬂammatory effect by
inhibition of TLR-4 expression. Also, the elevated KIM-1 expression
by FK506 is decreased by cotreatment with KRG. Thus, KGR can be
used as an adjuvant for the inhibition of adverse effect FK506 in the
kidney.
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